Type: Humanized monoclonal antibody fragment, antidote/anticoagulant reversal
Dosage Forms: 2.5g/50ml vial
Routes of Administration: IV
Common Trade Names: PRAXBIND
Idarucizumab
Tocilizumab
Sotrovimab
Obiltoxaximab
Sarilumab
Raxibacumab
Rituximab
Baricitinib